Protodioscin

CAS Number	55056-80-9 (verified against PubChem CID 441891)
Molecular Formula / MW	C51H84O22 / 1049.20 g/mol
Chemical Class	Furostanol-type steroidal saponin; a spirostanyl glycoside bearing a trisaccharide at C-3 and a glucose at C-26
Botanical Sources	Tribulus terrestris (gokshura; gokhru); also Dioscorea species
Plant Part(s)	Aerial parts and fruit
Typical Standardisation	Protodioscin by HPLC; 20–40% commercial range. Total saponins standardised separately
Claim Strength (Overview)	Emerging — the testosterone-boosting claim is not supported by human RCTs; sexual-function findings are mixed
Buy from Herbuno	Protodioscin 40% Powder (Tribulus Extract) | Standardized Tribulus terrestris → Protodioscin 20% Powder (Tribulus Extract) | Standardized Tribulus terrestris →

Name origin: Protodioscin is named for its relationship to dioscin — it is the furostanol precursor from which the spirostanol saponin dioscin is formed on enzymatic hydrolysis, the "proto-" prefix denoting that precursor status. Dioscin in turn takes its name from the genus Dioscorea (yam), honouring Dioscorides. Structurally protodioscin is a large steroidal saponin with a trisaccharide chain at C-3 and a glucose at C-26, the latter being the bond whose cleavage converts it to dioscin. Traditional use: Tribulus terrestris — gokshura in Ayurveda, gokhru in common Indian usage — has been used across Ayurvedic and Traditional Chinese practice primarily as a diuretic and urinary-tract remedy and as a vajikarana (aphrodisiac/vitalising) agent. The Sanskrit name means "cow’s hoof," describing the spiny fruit. It is worth noting that the traditional emphasis is at least as much urological as sexual, a nuance largely lost in the compound’s modern sports-supplement positioning. Research trajectory: Protodioscin’s modern trajectory is a cautionary tale about marketing outrunning evidence. Early animal work suggesting Tribulus raised testosterone and improved sexual behaviour was rapidly translated into a global "natural testosterone booster" category worth substantial sums. Human randomized controlled trials that followed have, with striking consistency, failed to reproduce the testosterone effect — a divergence this page documents plainly rather than eliding. Commercial source: Tribulus terrestris extract standardized to protodioscin content by HPLC; note that "saponins 40%" and "protodioscin 40%" are entirely different specifications from the same plant.

---

Evidence for Protodioscin Applications

The testosterone claim — the entire commercial basis of this ingredient category — is not supported by human evidence, and this must be stated first. A prospective study in men with unexplained infertility administered Tribulus terrestris at 750 mg/day in three divided doses for three months and found no statistically significant difference in total or free testosterone, in luteinizing hormone, or in any semen parameter (sperm concentration, motility, or abnormal forms) before versus after treatment, concluding that Tribulus terrestris was ineffective in the treatment of idiopathic infertility (Salač 2016). Claim strength: Emerging — the hormonal claim is not substantiated in humans.

The athletic-performance literature reaches convergent conclusions. A randomized, single-blind, placebo-controlled trial in 30 trained male CrossFit athletes given 770 mg/day of Tribulus terrestris or placebo for six weeks assessed body composition, testosterone and cortisol, and performance across five standard workouts; the paper notes plainly that in human studies Tribulus does not affect testosterone plasma levels in male boxers or rugby players (Fernández-Lázaro 2021). The pattern across the human literature is consistent enough that formulators should treat "testosterone booster" positioning for this ingredient as unsupported. Claim strength: Emerging.

Where the evidence is more genuinely mixed — and where an honest positioning might survive — is sexual function as a subjective endpoint, decoupled from hormones. A randomized, double-blind, placebo-controlled trial in male sexual dysfunction reported significant improvement in overall sexual function with a Tribulus extract, and a separate randomized double-blind placebo-controlled study in 60 women with hypoactive sexual desire disorder used a low-dose extract over four weeks with Female Sexual Function Index endpoints. It is notable and mechanistically puzzling that subjective sexual-function improvement can appear without measurable testosterone change; formulators should not paper over that gap by implying a hormonal mechanism the data does not support. Claim strength: Emerging.

A significant compositional caveat: protodioscin content in Tribulus terrestris varies dramatically with geographic origin, plant part, and harvest timing, with material from different regions differing by an order of magnitude. This is a plausible partial explanation for the inconsistency across trials — many studies used unstandardized or differently standardized extract, and some almost certainly delivered negligible protodioscin. It is a legitimate scientific point. It is not, however, a rescue for the testosterone claim, since trials using protodioscin-standardized material have also failed to show hormonal effects. Claim strength: Moderate (compositional).

Beyond the sexual-function positioning, protodioscin has attracted preclinical attention for antihyperlipidemic activity, with work in hyperlipidemic rats reporting altered triglyceride, cholesterol, and lipoprotein levels, and for cardiovascular and neuroprotective effects in cell models. These findings are real but entirely preclinical, and they do not currently support human claims. Their existence does, however, suggest the compound may be more scientifically interesting than its commercial history implies — just not in the way it has been sold. Claim strength: Emerging (preclinical only).

---

Dosage & Formulator Specification

Herbuno carries Tribulus terrestris extract standardized to 40% and 20% protodioscin by HPLC, alongside total-saponin-standardized Tribulus grades (90% and 40%) and unstandardized gokshura extract in powder, water-soluble, and oil-soluble formats. Buyers should note that "saponins 40%" and "protodioscin 40%" are entirely different specifications: total saponins is a much broader and less informative measure, and the two are not interchangeable.

Human trial dosing has used whole Tribulus extract in the range of roughly 750–770 mg/day over six weeks to three months in the studies cited above — without producing testosterone change. Given that the best-designed human evidence is null for the hormonal endpoint, it would be inappropriate to present any serving size as clinically validated for testosterone support. Formulators intending to work with this ingredient should scope claims to the sexual-function literature (itself modest and mixed) or to traditional urological positioning, and should size dose against the protodioscin assay rather than against extract weight.

Analytical verification should specify protodioscin by HPLC, not merely total saponins, since the two figures are unrelated in practice. Given the documented order-of-magnitude variation in protodioscin content with geographic origin, plant part, and harvest timing, provenance documentation carries more weight for this ingredient than for most, and buyers relying on a protodioscin claim should require batch-level assay rather than a specification sheet. Adulteration of Tribulus extracts with cheaper steroidal-saponin sources (notably Dioscorea) has been reported and warrants a saponin fingerprint check.

Tribulus terrestris is generally well tolerated in the clinical trial literature, with the sexual-dysfunction RCT reporting no drug-related serious adverse events and gastrointestinal upset being the most common complaint. Two points deserve statement. First, published trial protocols have recommended breaks every six to eight weeks rather than continuous use, with animal toxicity studies running to a maximum of eight weeks — meaning long-term safety data is genuinely limited. Second, and more importantly for a supplier: the honest position on this ingredient is that its dominant marketing claim is not supported by human evidence, and any customer positioning a product on testosterone elevation should be told so.

---

Frequently Asked Questions — Protodioscin

Does Tribulus / protodioscin raise testosterone?
No — human randomized trials consistently find it does not. A three-month study at 750 mg/day found no significant change in total or free testosterone, LH, or any semen parameter. The athletic literature reports the same: no effect on testosterone in boxers, rugby players, or CrossFit athletes. The "testosterone booster" positioning is not supported by human evidence.

Is there anything Tribulus does support?
Possibly subjective sexual function, decoupled from hormones. A randomized placebo-controlled trial in male sexual dysfunction reported improvement in overall sexual function, and a separate trial examined female hypoactive sexual desire. It is mechanistically puzzling that subjective improvement appears without testosterone change, and that gap should not be papered over.

Is "saponins 40%" the same as "protodioscin 40%"?
No, and confusing them is a real sourcing error. Total saponins is a much broader and far less informative measure. Protodioscin is one specific furostanol saponin within that fraction. The two figures are unrelated in practice and the specifications are not interchangeable.

Why does protodioscin content vary so much between suppliers?
Because it varies dramatically with geographic origin, plant part, and harvest timing — by up to an order of magnitude. This likely explains some inconsistency across trials. Batch-level assay, rather than a specification sheet, is the reasonable demand for anyone relying on a protodioscin claim.

Related compounds: Saponins, Withanolides, Ginsenosides, Gypenosides

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery